Patient characteristics
| . | AML Patients (n = 62) . | Control Patients (n = 22) . |
|---|---|---|
| Age (y)* | 64 (17-84) | 60 (17-82) |
| Sex (males/females) | 35/27 | 15/7 |
| FAB distribution† | 2 M0, 8 M1, 21 M2, 2 M3, 10 M4, 14 M5, 4 M6, 1 M7 | — |
| Percentage of leukemic blasts* (bone marrow) | 80 (30-99) | — |
| Disease | — | 1 Hodgkin's disease |
| 6 Non-Hodgkin's lymphomas | ||
| 2 Solid tumors | ||
| 13 Nonmalignant disorders |
| . | AML Patients (n = 62) . | Control Patients (n = 22) . |
|---|---|---|
| Age (y)* | 64 (17-84) | 60 (17-82) |
| Sex (males/females) | 35/27 | 15/7 |
| FAB distribution† | 2 M0, 8 M1, 21 M2, 2 M3, 10 M4, 14 M5, 4 M6, 1 M7 | — |
| Percentage of leukemic blasts* (bone marrow) | 80 (30-99) | — |
| Disease | — | 1 Hodgkin's disease |
| 6 Non-Hodgkin's lymphomas | ||
| 2 Solid tumors | ||
| 13 Nonmalignant disorders |